These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17988965)

  • 21. Rationale for probiotic treatment strategies in inflammatory bowel disease.
    Schultz M; Lindström AL
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do probiotics have a role in the management of inflammatory bowel disease?
    Morris JD; Diamond KA; Balart LA
    J La State Med Soc; 2009; 161(3):155-9. PubMed ID: 19772038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently?
    Griffiths AM
    Dig Dis; 2009; 27(3):404-11. PubMed ID: 19786772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, genes and inflammatory bowel diseases in childhood.
    de Mesquita MB; Civitelli F; Levine A
    Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: The clinical importance of growth in children with inflammatory bowel disease: is it important to the gastroenterologist?
    Taminiau JA
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():53-6. PubMed ID: 18081649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis.
    Gross V
    Expert Opin Pharmacother; 2008 May; 9(7):1257-65. PubMed ID: 18422482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic surgery for inflammatory bowel diseases.
    Person B
    Minerva Chir; 2008 Apr; 63(2):151-60. PubMed ID: 18427446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeat endoscopy affects patient management in pediatric inflammatory bowel disease.
    Thakkar K; Lucia CJ; Ferry GD; McDuffie A; Watson K; Tsou M; Gilger MA
    Am J Gastroenterol; 2009 Mar; 104(3):722-7. PubMed ID: 19209163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carbonyl groups content in serum proteins as an indicator of disease activity in children with inflammatory bowel diseases and its dependence on the other markers of inflammatory process].
    Krzesiek E; Pytrus T; Kosmowska A; Iwańczak B
    Pol Merkur Lekarski; 2008 Dec; 25(150):455-9. PubMed ID: 19205373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic inflammatory bowel diseases in children and adolescents].
    Ashorn M; Iltanen S; Kolho KL
    Duodecim; 2009; 125(17):1849-56. PubMed ID: 19860088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission.
    Nguyen DL; Limketkai B; Medici V; Saire Mendoza M; Palmer L; Bechtold M
    Curr Gastroenterol Rep; 2016 Oct; 18(10):55. PubMed ID: 27637649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory bowel disease and cerebrovascular arterial and venous thromboembolic events in 4 pediatric patients: a case series and review of the literature.
    Standridge S; de los Reyes E
    J Child Neurol; 2008 Jan; 23(1):59-66. PubMed ID: 18184942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of corticosteroids, immunomodulators, and infliximab at a third-level Day-Hospital Service of Gastro-Hepatology.
    Actis GC; Pellicano R; Bugianesi E; Lagget M; Rizzetto M
    Minerva Gastroenterol Dietol; 2008 Sep; 54(3):239-42. PubMed ID: 18614972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy.
    Hanai H
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):596-600. PubMed ID: 18679059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nutritional Support of Patient with Inflammatory Bowel Disease.
    Montgomery SC; Williams CM; Maxwell PJ
    Surg Clin North Am; 2015 Dec; 95(6):1271-9, vii. PubMed ID: 26596927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.